Hydrogel For Wound

Wholesale amorphous hydrogel for chronic and acute wound care. Formulated with high-water biopolymers to donate moisture, induce autolytic debridement, and accelerate tissue re-epithelialization.

This amorphous hydrogel for wound care functions as a sterile, high-moisture primary coupling substrate engineered for chronic ulcers, partial-thickness burns, pressure sores, and necrotic surgical wounds. Achieving rapid tissue re-epithelialization requires maintaining a physiologically optimal, moist wound environment without causing tissue maceration. When applied directly into deep, sloughy wound beds, this high-water biopolymer matrix acts as a selective moisture donor: it rehydrates hard necrotic eschar to induce autolytic debridement while absorbing excess exuded fluids into its cross-linked polymer lattice. The secondary clinical engineering objective is sealing nerve endings to deliver instant local pain mitigation during dressing changes. We compound and tube-package these sterile-ready blanks for wound dressing packagers, clinical supply stockists, and pharmaceutical OEMs.

The industrial synthesis of wound hydrogel utilizes a high-molecular-weight cross-linked carboxymethylcellulose (CMC) or polyacrylamide hydro-polymer system, neutralized with alkanolamine buffers inside 316L stainless steel vacuum reactors. To prevent bioburden contamination and ensure SAL 10-6 sterility, the liquid compounding phase is executed using medical-grade reverse-osmosis (RO) water (< 1.0muS/cm). The solution undergoes high-vacuum degassing (0.08 MPa) to strip atmospheric micro-bubbles, eliminating oxygen voids that inhibit tissue healing. The thick gel is pumped into medical-grade aluminum or laminated PE squeeze tubes fitted with tamper-evident seals. Completed tube lots undergo terminal gamma radiation or steam autoclaving that cures the polymer cross-links while killing endospores without degrading gel viscosity. 

• Autolytic Debridement Kinetics (Selective Eschar Rehydration) 

  Hard, dry necrotic tissue and yellow slough act as physical barriers that block granulating tissue growth and foster bacterial colonization. Surgical debridement can damage underlying healthy tissue. Our wound hydrogel operates via selective moisture donation: its high-water phase (>80%) transfers moisture into the dry eschar via osmotic gradient action, rehydrating dead cellular debris. This softening activates the body's natural endogenous proteolytic enzymes, breaking down necrotic bonds and allowing pain-free removal of slough during routine saline irrigation without injuring fragile, nascent capillary beds.

   

• Non-Adherent Fluid Balancing (Trauma-Free Dressing Removal) 

  Secondary wound dressings frequently adhere directly to delicate granulating tissue; when ripped off during dressing changes, they strip newly formed epithelial cells, resetting the wound healing clock and causing severe patient pain. Our hydrogel forms a soft, cohesive physical shield over the raw wound bed. The gel matrix maintains a fluid boundary that prevents secondary gauze or foam dressings from drying out and sticking directly to the wound surface. During dressing replacement, the gel washes away cleanly with sterile saline, preserving newly regenerated tissue.

   

• Micro-Vapor Transmission Shield (Maceration Defense) 

  While a moist environment accelerates tissue migration, excessive trapped exudate leads to wound margin maceration, breaking down healthy surrounding skin. Our amorphous gel polymer matrix combines high water-donating capacity with dynamic moisture vapor transmission (MVTR > 1800 g/m²/24h). As the gel absorbs excess proteinaceous fluid from the wound, the polymer lattice allows water vapor to evaporate naturally through the secondary breathable dressing, maintaining an equilibrium that prevents fluid accumulation and peri-wound tissue breakdown.

• Tamper-Evident Barrier Tube Packaging : Moisture loss or gas exchange will compromise hydrogel sterility and debridement kinetics. Completed wound gel is packaged in multi-layer PE/AL laminated tubes with orifice blind seals and tamper-evident caps. Tubes are desiccant-packed inside reinforced corrugated shipping cartons to withstand global air and ocean freight pressure shifts. 

• Transnational Supply Chain Routing : Polymer synthesis, deionization purification, and high-vacuum fluid compounding execute natively inside our primary China facility. Sterile tube filling, gamma irradiation clearance, cartoning, and export palletization route through our Vietnam hub, protecting global B2B procurement networks from regional medical trade tariffs.

• ISO 10993 Complete Biocompatibility : Cured hydrogel extractions undergo independent clinical laboratory testing against strict ISO 10993-5 (Cytotoxicity Grade 0), ISO 10993-10 (Sensitization), and ISO 10993-23 (Dermal Irritation Index <0.1) boundaries, confirming zero skin sensitization or delayed-type hypersensitivity. 

• MDSAP Certified Cleanroom Converting : Compounding reactors and automated filling lines function inside ISO Class 7 cleanrooms audited and registered to ISO 13485:2016 and MDSAP quality frameworks, delivering unbroken lot-serialization from raw polymers to outbound shipping pallets.

Wound care procurement networks, hospital GPO directors, and pharmaceutical device OEMs can request SAL 10^-6 sterility validation reports, autolytic debridement clinical datasheets, and trial 15g evaluation tube samples. 

👉 [Request Wound Hydrogel Samples]

Hot Tags: hydrogel for wound, China hydrogel for wound manufacturers, suppliers, factory, Medical Hydrogel, Hydrogel